July 01, 2024 at 10:50 am

Spectral AI Added to Russell Microcap® Index

Spectral AI, Inc. (Nasdaq: MDAI) has been included in the Russell Microcap Index as of July 1, 2024, following the annual index reconstitution. This inclusion marks a significant milestone for the Dallas-based AI company, which specializes in medical diagnostics. Key Points: Index Inclusion: Spectral AI’s entry into the Russell Microcap Index is expected to increase… [Read More]
July 01, 2024 at 10:21 am

American Metals LLC Agrees to Business Combination with AI Transportation Acquisition Corp, Shares Rise 14%

American Resources Corporation’s (NASDAQ: AREC) subsidiary, American Metals LLC (Nasdaq: AITR), has executed a business combination agreement with Nasdaq-listed AI Transportation Acquisition Corp. This strategic move is poised to enhance American Metals’ capabilities in recycling critical metals crucial for the electrified economy. Highlights: The business combination represents a total equity value of USD 170 million… [Read More]
July 01, 2024 at 10:15 am

Humacyte’s ATEV Receives FDA Designation for PAD Treatment, Stock Soars 24%

Humacyte, Inc. (Nasdaq: HUMA) has announced significant regulatory progress for its Acellular Tissue Engineered Vessel (ATEV), receiving the FDA’s Regenerative Medicine Advanced Therapy (RMAT) designation for treating advanced Peripheral Artery Disease (PAD). This marks the third RMAT designation for ATEV, reflecting its potential in various medical applications. Key Highlights: FDA RMAT Designation: Humacyte’s ATEV has… [Read More]
July 01, 2024 at 10:04 am

Stock Market Gains as Traders Navigate French Election Results and Await US Jobs Data

As the month begins, global markets responded positively, buoyed by the unfolding economic landscape and recent French election results. Traders are keenly awaiting a series of critical economic reports, including the pivotal US jobs report due on Friday, which is expected to influence the Federal Reserve’s forthcoming decisions. In Europe, markets rebounded from a four-day… [Read More]
July 01, 2024 at 9:11 am

Ligand Pharmaceuticals Partner Secures FDA Approval for First COPD Treatment in Two Decades

Verona Pharma plc, partner to Ligand Pharmaceuticals (Nasdaq: LGND), has received FDA approval for Ohtuvayre™ (ensifentrine). Ohtuvayre is the first inhaled product with a novel mechanism of action available for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients in more than 20 years. Ligand’s shares climbed COPD causes breathing problems including… [Read More]
June 28, 2024 at 1:38 pm

Red, White and Blue Shines Through as American Outdoor Brands (AOUT) Beats Estimates and Posts Positive Q4 Financials

The PRISM Consumer Products Index company American Outdoor Brands (AOUT) announced its Q4 financial results that beat on EPS $0.00 vs FactSet ($0.07) and revenues $46.3M vs FactSet $43.1M. Adjusted EBITDA also came in above consensus at $1.0M vs FactSet $0.4M. American Outdoor Brands, Chief Financial Officer, Andrew Fulmer stated, “In FY24, we grew our business,… [Read More]
June 28, 2024 at 1:07 pm

Market Summary: S&P 500 Retreats as Tech Giants Falter

Despite a quarter marked by strong rallies fueled by anticipations of Federal Reserve rate cuts, stocks erased their gains on the last day. The S&P 500 reversed an earlier gain of nearly 1%, primarily due to losses in technology megacaps. Similarly, the Nasdaq 100 fell after just surpassing the 20,000 mark for the first time…. [Read More]
June 28, 2024 at 8:41 am

BioXcel Announces Positive Topline Results in Schizophrenia Study

BioXcel Therapeutics (Nasdaq: BTAI) has reported positive topline results from a post-marketing requirement (PMR) study of its IGALMI™ (dexmedetomidine) sublingual film treatment for schizophrenia. The study demonstrated no evidence of tachyphylaxis, tolerance, or withdrawal with the 180 mcg dose after seven days of PRN (as-needed) treatment. The single-arm, open-label study enrolled 28 inpatient adults with… [Read More]